The primary source for this Ocrevus PML case report is a JAMA Neurology Brief Report item dated March 16, 2021, “Progressive Multifocal Leukoencephalopathy in a Patient With Progressive Multiple Sclerosis Treated With Ocrelizumab Monotherapy”. From the Abstract for that medical journal article we take this excerpt: Conclusions and … [Read more...]
Ocrevus Patient Gets Progressive Multifocal Leukoencephalopathy (PML)
A May 24, 2017 Reuters news report, “Deadly brain infection in German MS patient prompts Roche investigation”, brings some unwanted attention to a potential drug safety issue for Ocrevus (ocrelizumab injection) which may negatively affect this projected sales success. From this recent Reuters article: A person in Germany treated with Roche Holding … [Read more...]